Pharma & Biotech

Boehringer Ingelheim Awarded ‘Global Top Employer’ for Fourth Consecutive Year, Recognized for Employee Development and Wellbeing Focus

(IN BRIEF) Boehringer Ingelheim has been honored by the Top Employers Institute with a "Global Top Employer" certification for the…

2 years ago

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million)…

2 years ago

Empa Researchers Develop Nanoparticle Soldering for Minimally Invasive Surgery

(IN BRIEF) Empa researchers have developed an innovative technique using nanoparticles for soldering wounds, potentially revolutionizing wound closure methods. This…

2 years ago

Basilea Pharmaceutica Acquires Novel Antibiotics Program Targeting Multidrug-Resistant Gram-Negative Bacteria

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN), a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced…

2 years ago

Evonik Honored with Cefic Responsible Care® Award for Sustainable Biosurfactants

(IN BRIEF) Evonik has been awarded the Responsible Care® Award by the European Chemical Industry Council (Cefic) in the "Safe…

2 years ago

Accenture Ventures Invests in QuantHealth to Accelerate AI-Powered Clinical Trial Design

(IN BRIEF) Accenture has announced a strategic investment through Accenture Ventures in QuantHealth, an AI-powered clinical trial design company specializing…

2 years ago

Global Life Sciences M&A Surges to $191 Billion in 2023, Driven by Big Pharma’s Big Deals

(IN BRIEF) The global life sciences industry has witnessed a resurgence in mergers and acquisitions (M&A) activity, with investments totaling…

2 years ago

Merck KGaA Partners with Inspirna to Advance Novel Therapy for RAS-mutated Colorectal Cancer

(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class…

2 years ago

Novo Nordisk Initiates Groundbreaking Collaborations for Innovative Obesity and MASH Treatments

(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches…

2 years ago